Summary
A Phase IIb, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the safety, tolerability and efficacy of Study Drug in adults with chronic hepatitis C virus infection.
Register to download
PRA Exceeds Tough Enrollment Goals
You may also be interested in:
Webcast
Introduction to Patient Feasibility
Patient Feasibility is an area under-explored in the clinical trial industry. Currently, protocol and site feasibility are the primary methods of…
View Resource
Case Study
Persistence Leads To High Enrollment
A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in…
View Resource
Webcast
Easing the Rare Disease Patient’s Burden in Clinical Trials with Innovative Technology
In this webinar, you will learn how technology can influence rare disease clinical study design, increase the speed of research and thereby reduce…
View Resource
View all related content and resources for Patient Recruitment and Retention
Explore Insights